Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Bullboard Posts
Post by mmarquison Apr 25, 2002 9:15pm
203 Views
Post# 5048880

Help with Information

Help with InformationHello ONC Board Members: I have not followed Biotech and did not even hear of ONC until Monday past when I came upon it while doing research for my Sis-in-law who has brain tumor. So I have a dual interest now, a concerned relative and a potential investor. I've only been able to scratch the surface regarding DD and in understanding this company as an investment prospect. Unfortunately, have not had much time to DD but reading the board has raised some questions (Who is BCY and what's the relationship?, Considering the recent announcement of trials-approvals and the apparent success of Glio Blast treatment, why is this board so dead? Why is the price falling whn the news should be giving it a huge upward momentum?, ETC.) Maybe some of the longtime followers wouuld be so kind as to bring me up to speed with a quick overview..TIA MM
Bullboard Posts